Maria R. Costanzo et al. JCHF 2016;4:

Slides:

Advertisements

Similar presentations

NCEP ATP IV GuidelineS: 2013 Update

Advertisements

Chapter 20 Heart Failure.

Chronicle Offers Management to Patients with Advanced Signs and Symptoms of Heart Failure Presented at American College of Cardiology Scientific Sessions.

Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? Systolic.

Value of Endothelin Receptor Inhibition with Tezosentan in Acute Heart Failure Studies VERITAS Trial Presented at The American College of Cardiology Scientific.

Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Beta-Blockers and Outcome in Heart Failure and Atrial.

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: Overview of the 2011 Food and Drug Administration.

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pulmonary Arterial Hypertension J Am Coll Cardiol.

Algorithm for guideline-directed medical therapy for patients with stable ischemic heart disease. The use of bile acid sequestrant is relatively contraindicated.

Evidence-based treatment algorithm, including clinical trials published through A, B, and C are levels of evidence defined as follows—Level of Evidence:

Glenn N. Levine et al. JACC 2016;68:

Clyde W. Yancy et al. JACC 2017;70:

Clyde W. Yancy et al. JACC 2017;70:

Irbedrin Group Training

Shadi Al Halabi et al. JACEP 2015;1:

Dean J. Kereiakes et al. JACC 2017;70:

G. Michael Felker et al. JCHF 2014;2:

Carolyn Y. Ho et al. JCHF 2015;3:

Belinda Gray et al. JCHF 2013;1:

Table of Contents Why Do We Treat Hypertension? Recommendation 5

Prakash Harikrishnan et al. JACEP 2015;1:

Gregory Piazza et al. JCIN 2015;8:

Wayne L. Miller et al. JCHF 2013;1:

Peter F. Aziz et al. JACEP 2015;1:62-70

Mohit K. Turagam et al. JACEP 2017;3:

Mahesh Anantha Narayanan et al. JACEP 2017;3:

Khurram Nasir et al. JACC 2015;66:

Jordan B. King et al. JCHF 2016;4:

CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.

G. Michael Felker et al. JCHF 2014;2:

Svend A. Mortensen et al. JCHF 2014;2:

Nicolaj C. Hansson et al. JACC 2016;68:

Kenshi Hayashi et al. JACEP 2016;2:

Connie W. Tsao et al. JCHF 2016;4:

Rami Doukky et al. JCHF 2016;4:24-35

Jennifer T. Thibodeau et al. JCHF 2014;2:24-31

Neal A. Chatterjee et al. JCHF 2014;2:

Gordon R. Reeves et al. JCHF 2017;j.jchf

William T. Abraham et al. JCHF 2015;3:

Peter E. Carson et al. JCHF 2015;3:

Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies (2,9) Green diamonds indicate Class I guideline recommendations, while.

Emilce Trucco et al. JACEP 2018;j.jacep

Jennifer T. Thibodeau et al. JCHF 2014;2:24-31

Mahesh Anantha Narayanan et al. JACEP 2017;j.jacep

Rami Doukky et al. JCHF 2016;4:24-35

John Rickard et al. JCHF 2013;1:

Arman Qamar et al. JACC 2018;71:

Leo F. Buckley et al. JCHF 2016;4:1-8

Maria Rosa Costanzo et al. JCHF 2016;4:95-105

Glenn N. Levine et al. JACC 2011;58:e44-e122

Jordan B. King et al. JCHF 2016;4:

Lee A. Fleisher et al. JACC 2014;64:e77-e137

Natasha A. Loghmanpour et al. JCHF 2016;4:

Connie W. Tsao et al. JCHF 2016;4:

Saadia Sherazi et al. JACEP 2015;1:74-80

Steven R. Steinhubl, and Eric J. Topol JACC 2015;66:

Gregory Piazza et al. JCIN 2015;8:

Khadijah Breathett et al. JCHF 2017;5:

Rick A. Nishimura et al. JACC 2017;70:

Dennis M. McNamara et al. JCHF 2014;2:

Zeenat Safdar et al. JCHF 2014;2:

Zeenat Safdar et al. JCHF 2014;2:

Jeffrey Senfield et al. JACEP 2017;3:

John J.V. McMurray et al. JCHF 2018;6:8-17

Maxime Berthelot-Richer et al. JIMG 2016;9:

Orly Vardeny et al. JCHF 2016;4:

Maria R. Costanzo et al. JCHF 2016;4:

Gianluigi Savarese et al. JCHF 2016;4:

Leah M. Wright et al. JIMG 2016;9:

Constantijn Franssen et al. JCHF 2016;4:

Presentation transcript:

Maria R. Costanzo et al. JCHF 2016;4:333-344 Pulmonary Artery Pressure Treatment Guidelines The PA pressure treatment guidelines for the CHAMPION trial used a treatment algorithm in response to patient hemodynamic trend data. The low PA pressure and elevated PA pressure algorithms implemented change protocols for diuretic and/or vasodilator therapies to achieve hemodynamic stabilization. In the presence of normal PA pressures, continuation of existing patient treatment regimens with consideration for further uptitration of guideline-directed medical therapy was recommended. ACC = American College of Cardiology; AHA = American Heart Association; CHAMPION = CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in Class III Heart Failure; IV = intravenous; PA = pulmonary artery. Maria R. Costanzo et al. JCHF 2016;4:333-344 American College of Cardiology Foundation